Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

ETC-216 – Phospholipid

Drug (Brand/Generic)

ETC-216

Company/Licensee

Esperion Therapeutics / Pfizer

Therapy Class

Phospholipid

Product Description

Synthetic variant of HDL

Current Indication

Treatment of atherosclerosis

Market Sector

CVD

Development Status

Phase II
Expand

Go Top